Screener / SEC EDGAR /CIK 0001321732 /10-K filed Feb 25, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

Penumbra Inc PEN

Compare with peers Embed
What it said it expected, against what it reported

1 target with a reported result

Releases of the last 3 years
Above the range 0 above the last range given
Within the range 1 of 1 range targets
Below the range 0 below the last range given

The numbers PEN said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
Revenue
Fiscal 2024 (ended Dec 31, 2024)
Given $1.23B to $1.27B release Feb 22, 2024
Kept $1.23B to $1.27B release May 7, 2024
Lowered $1.18B to $1.20B release Jul 30, 2024
Kept $1.18B to $1.20B release Oct 30, 2024
$1.19B
10-K filed 2025-02-18
Within the range
The company's words
The Company projects total revenue for 2024 to be in the range of $1,230.0 million to $1,270.0 million, representing year over year growth of 16% to 20% compared to 2023 revenue of $1,058.5 million. release Feb 22, 2024
The Company reiterates guidance for total revenue for 2024 to be in the range of $1,230.0 million to $1,270.0 million, representing year over year growth of 16% to 20% compared to 2023 revenue of $1,058.5 million. release May 7, 2024
The Company is updating its guidance range for 2024 total revenue to $1,180 million to $1,200 million, which is a reduction of $60 million at the midpoint from its previous guidance range of $1,230 million to $1,270 million. release Jul 30, 2024
The Company reiterates guidance for total revenue for 2024 to be in the range of $1,180.0 million to $1,200.0 million. release Oct 30, 2024
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2024-02-22), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PEN/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.